MustGrow Biologics Corp.
MGROF
$0.32
-$0.02-6.58%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.98% | -45.72% | -2,436.37% | -1,106.26% | -648.88% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 686.13% | -38.42% | -87.24% | -70.08% | -82.54% |
| Change in Net Operating Assets | 320.12% | 815.38% | 215.42% | 78.22% | -31.84% |
| Cash from Operations | 38.07% | -35.98% | -1,190.90% | -2,525.69% | -1,613.04% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14,142.67% | -- | -- | -- | -- |
| Total Debt Issued | -27.35% | -- | -- | -- | -- |
| Total Debt Repaid | 53.21% | 53.21% | 54.99% | 98.22% | -- |
| Issuance of Common Stock | -- | -- | -- | 37.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -207.14% | -- | -- | -- | -- |
| Cash from Financing | 63.54% | 1,900.85% | 1,902.61% | 1,902.00% | 2,174.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.13% | 47.78% | 59.54% | -701.89% | -1,400.22% |